Register online now using coupon code FLASH30 and get 30% off tickets until midnight tomorrow (Wednesday 17th April 2019).
The organisers say: "Over the previous 20 years we have seen a significant change in the healthcare industry. Small molecules have been pushed out of the blockbuster limelight by biologics. Decreasing sequencing cost has allowed more targeted R&D and the use of increasingly interdisciplinary data to influence prognosis has become standard practice. All of this points to a healthcare future with an increasingly personalized approach. But how will this future come together?"
Why should you attend Health Horizons?
- Network with biotechnology and healthcare leaders, investors and pharma assembling to address key issues facing the wider healthcare sector.
- Partner with top companies locally and from around the world.
- Hear from keynote speakers and key opinion leaders.
- Expand your knowledge.
- Understand current trends and insights into the shifts in the healthcare industry.
- Discover new technologies and the latest technological innovations.
- Immerse yourself in Cambridge - the global hub of healthcare innovation.
Find out more>>>>
Meet Key Opinion Leaders
- Rory O’Connor - SVP, Chief Medical Officer, Pfizer
- Mene Pangalos, Executive Vice President, AstraZeneca
- Dr. Aubrey de Grey - Chief Science Officer, SENS Foundation
- Dr. Maria Aguirre Rueda - Director of Health Research & Innovation, Basque Ministry of Health
- Hermann Hauser - Co-founder, Amadeus Capital Partners
- Prof. Joanne Hackett - Chief Commercial Officer, Genomics England
- Claude Bertrand, Executive Vice President R&D, Chief Science Officer, Servier
- John Isaac, Senior Director Neuroscience, Johnson & Johnson Innovation
- Vishal Gulati, Partner; Draper Esprit
- Beatriz Silva-Lima, Professor of Pharmacology and Regulatory Science, Universidade de Lisboa
- Anne Blackwood, CEO, Health Enterprise East
- Chris Lowe, Director, Cambridge Academy of Therapeutic Sciences
- Solange Corriol Rohou, Sr. Director for Regulatory Affairs & Policy for Europe, Astrazeneca
- Robert Tansley, Operating Partner, Cambridge Innovation Capital
- Paul-Pater Tak, Venture Partner, Flagship Pioneering
...and many more.
View speakers >>>
Meet leading investors
- Flagship Pioneering
- Apollo Ventures
- Cambridge Innovation Capital
- Arix Bioscience
- Catapult Ventures
- AlbionVC
- Amadeus Capital Partners
- Level 8 Ventures
- Ventac Partners
- Draper Esprit
- DNB Bank
- Eli Lilly Ventures
- o2h Ventures
- Playfair Capital
- Cambridge Enterprise
- Sentinel Oncology
- Brook Street Equity
- BioCity
- Arrowfield Capital
- Longwall Ventures